David Weill, Director at TransMedics Group, Inc. (TMDX), bought 10,000 shares at $17.00 ($170K) on 2019-11-11, disclosed to the SEC on 2019-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TMDX | SELL | 2025-12-05 | $1.4M | — | Filing → |
| TMDX | SELL | 2025-05-23 | $181K | — | Filing → |
| TMDX | SELL | 2024-05-31 | $338K | — | Filing → |